Sanofi and GlaxoSmithKline’s next generation Covid-19 vaccine could be used as a booster, after new data suggested that it elicits a strong immune response against the Omicron variant.
賽諾菲(Sanofi)和葛蘭素史克(GlaxoSmithKline)的下一代新冠疫苗可以用作加強針,此前新的數據表明,該疫苗對奧密克戎變體引發了強烈的免疫反應。
您已閱讀8%(265字),剩余92%(3193字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。